Ticker

No recent analyst price targets found for MYCOF.

Latest News for MYCOF

Noveris Health Sciences Joins the Biotechnology Innovation Organization (BIO)

VANCOUVER, BC, Canada – TheNewswire - July 17, 2026 — Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) (“Noveris” or the “Company”) is pleased to announce that it has joined the Biotechnology Innovation Organization (“BIO”), the world's largest advocacy association representing biotechnology companies, academic and research institutions, state and regional biotechnology centers and related…

TheNewswire • Jul 17, 2026
Noveris Health Sciences Joins Life Sciences BC

VANCOUVER, BC, Canada – TheNewswire - July 14, 2026 — Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) ("Noveris" or the "Company") is pleased to announce that, effective July 13, 2026, it has joined Life Sciences British Columbia ("Life Sciences BC" or "LSBC"), the not-for-profit industry association that supports and represents British Columbia's life sciences community through leadership,…

TheNewswire • Jul 14, 2026
Noveris Health Sciences Announces Upcoming AGM and Record Date, and receipt of CSE Notice

VANCOUVER, BC, Canada – TheNewswire - June 29, 2026 — Noveris Health Sciences Inc. (CSE: NVRS; FSE: 0NF0; OTC: MYCOF) (“ Noveris ” or the “ Company ”) is pleased to announce that its annual general meeting of shareholders (the " Meeting ") will be held on September 4, 2026 at 1890-1075 West Georgia Street, Vancouver, British Columbia. The record date for the meeting has been set for July 21, 2026.   At the Meeting,…

TheNewswire • Jun 29, 2026
Noveris Health Sciences Announces Appointment Of Nathan Mison As Chair Of Advisory Board

Vancouver, British Columbia – June 12, 2026 – TheNewswire – Noveris Health Sciences Inc. (“Noveris” or the “Company”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) is pleased to announce the appointment of Nathan Mison as Chair of the Company's Advisory Board. The Advisory Board has been established by the Company's Board of Directors to provide management and the Board with access to additional external expertise as the…

TheNewswire • Jun 12, 2026
Noveris Health Sciences Appoints Geoff Griffiths As Strategic Advisor To Support Commercialization And Growth Initiatives

VANCOUVER, British Columbia, JUNE 8, 2026 - TheNewswire – Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) (“Noveris” or the “Company”) is pleased to announce the appointment of Geoff Griffiths as Strategic Advisor to the Company. Mr. Griffiths is a seasoned life sciences executive with more than 25 years of experience spanning the pharmaceutical, biotechnology, and technology sectors. Throughout…

TheNewswire • Jun 8, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for MYCOF.

No Senate trades found for MYCOF.

No House trades found for MYCOF.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top